Abbott India Ltd share price logo

Abbott India Ltd Share Price

(ABBOTINDIA)

₹300601.35%

as on 04:01PM, 24 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Abbott India Ltd Performance

  • Day's Low

    Day's High

    ₹30,010
    Day's Price Range
    ₹30,680
  • 52 Week's Low

    52 Week's High

    ₹25,200
    52-Week Price Range
    ₹31,898.95
1 Month Return-3.35 %
3 Month Return+ 13.36 %
1 Year Return+ 17.08 %
Previous Close₹30,470.00
Open₹30,680.00
Volume6,809.00
Upper Circuit₹36,560.00
Lower Circuit₹24,380.00
Market Cap₹63,877.50Cr

Abbott India Ltd Fundamentals

P/E Ratio

0

PEG Ratio

0

Market Cap

₹63,877.50 Cr

P/B Ratio

15.48

EPS

35.67

Dividend Yield

0

Sector

Pharmaceuticals

ROE

34.88

Abbott India Ltd Analyst Rating

based on 8 analysts

BUY

75.00%

Buy

0.00%

Hold

25.00%

Sell

Based on 8 analysts offering long term price targets for Abbott India Ltd. An average target of ₹30645.25

Source: S&P Global Market Intelligence

Abbott India Ltd Share analysis

Abbott India Ltd price forecast by 8 analysts

Upside of1.95%

High

₹35292

Target

₹30645.25

Low

₹17872

Abbott India Ltd target price ₹30645.25, a slight upside of 1.95% compared to current price of ₹30060. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Key events for Abbott India Ltd

  • Abbott India Reports Strong Q3 25 Performance - 04 Apr, 2025

    Abbott India achieved a 12.3% revenue increase in Q3 25, reaching INR16.1bn, with net profit rising 15.7% to INR3.6bn. The company’s share price hit an all-time high of INR31,900 following these results. Analysts project continued growth, with revenue expected to reach INR78.3bn by FY 27.

Insights on Abbott India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.69% to 7.77% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ABBOTINDIA stock has moved up by 11.7%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.16% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 143.9% return, outperforming this stock by 70.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.99% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 55.3% return, outperforming this stock by 35.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.85% to 15.84% in Dec 2024 quarter

Abbott India Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹3,850.06Cr (-)₹4,233.27Cr (↑9.95%)₹4,563.66Cr (↑7.80%)₹5,201.54Cr (↑13.98%)
Total Liabilities₹1,247.90Cr (-)₹1,413.48Cr (↑13.27%)₹1,375.12Cr (↓2.71%)₹1,502.65Cr (↑9.27%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹626.13Cr (-)₹726.74Cr (↑16.07%)₹947.66Cr (↑30.40%)₹893.39Cr (↓5.73%)₹1,212.81Cr (↑35.75%)

Abbott India Ltd Index Inclusions

BSE Mid-Cap

₹43,590.49

-0.16 (-69.87%)

BSE 200

₹10,993.55

-0.26 (-28.44%)

S&P BSE Low Volatility

₹1,778.72

0.02 (0.29%)

BSE Healthcare

₹42,929.75

0.55 (236.74%)

Nifty MNC

₹27,223.30

-0.58 (-157.75%)

S&P BSE Quality

₹1,754.46

-0.26 (-4.64%)

Nifty Healthcare

₹14,173.35

0.4 (56.1%)

Nifty 500

₹22,180.65

-0.26 (-56.95%)

NIFTY PHARMA

₹21,974.60

1.08 (235.65%)

S&P BSE 250 LargeMidCap

₹10,401.21

-0.27 (-27.69%)

S&P BSE 400 MidSmallCap

₹11,334.15

-0.09 (-9.8%)

S&P BSE 150 MidCap

₹15,145.83

-0.16 (-24.7%)

Nifty LargeMidcap 250

₹15,485.00

-0.24 (-36.85%)

Nifty Midcap 150

₹20,194.40

-0.17 (-34.65%)

Nifty MidSmallcap 400

₹18,655.75

-0.13 (-24.05%)

BSE 500

₹34,880.67

-0.23 (-82.11%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Abbott India Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
74.99%
0.00
Foreign Institutions
0.16%
0.00
Mutual Funds
7.77%
1.11
Retail Investors
15.84%
-0.05
Others
1.23%
-5.90

Abbott India Ltd Key Indicators

Details2002
Book Value Per Share (₹)106.54
Details2002
Earning Per Share (₹)35.67
Details20202021202220232024
Return On Equity %26.7127.4429.4631.634.88

Abbott India Ltd Earnings and Dividends

  • Abbott India Ltd Earnings Results

    Abbott India Ltd’s net profit jumped 16.01% since last year same period to ₹360.78Cr in the Q3 2024-2025. On a quarterly growth basis, Abbott India Ltd has generated 0.61% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Abbott India Ltd Dividends May,2024

    In the quarter ending March 2024, Abbott India Ltd has declared dividend of ₹410 - translating a dividend yield of 2.45%.

    Read More about Dividends

Abbott India Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Abbott India Ltd is currently in a Bullish trading position according to technical analysis indicators.

Abbott India Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹63,877.50 Cr15.4%0.53NANA
BUY₹15,129.56 Cr-2.79%0.52₹602 Cr₹2,851 Cr
BUY₹73,699.36 Cr19.69%0.56₹3,168 Cr₹29,001 Cr
HOLD₹88,573.75 Cr32.73%0.64₹3,854 Cr₹19,547 Cr
BUY₹49,398.80 Cr20.4%0.56₹589 Cr₹3,453 Cr

About Abbott India Ltd

Abbott India Ltd is a leading multinational pharmaceutical company in India, with its headquarters in Mumbai. It has manufacturing facilities in Goa and independent contract/third party manufacturers based across the country. The company provides products and solutions across therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, MultiSpecialty, Vaccines and Consumer Health. In 2002, they sold their Jejuri Undertakings with assets and liabilities as a going concern. In 2003, they amalgamated Knoll Pharmaceuticals Ltd with the company. In 2004, they started capsule production with a capacity of 27 million nos. and in 2005, they further increased the capacity to 56 million nos. and started a new project of producing nutritional products with installed capacity of 600 tonnes. In 2006, the production capacity of Tablets was also increased by 236 million nos to 686 million. In 2008, they launched Digene Total buffered pantoprazole tablet, Bruge, and Thyronorm 150 Digene along with Sugar Free Tablet and Gel. In 2018, Abbott India Ltd formed a new Business Unit GI Advance which followed a Build Operate Transfer model. During the year 2020-21, the company made an innovation in Brufen Coating formula leading to 50% increase in coating installed capacity. It further executed 8 new studies and published 8 articles in major indexed journals. Abbott India also launched 10 new products in various therapy segments leading to their recognition as The Most Innovative MNC of the Year 2019 at the 12th Pharma Leaders Award. The Drug Price Control Order 2013 brought several products of Abbott India under price control, leading to an adverse impact on sales and profits. They also received approvals to conduct phase 3 studies in adults/eldery and pediatric for their Influvac Quadrivalent Vaccine QIV Program. Abbott India has been making continuous efforts for portfolio expansion launching unique products and leveraging technology for better healthcare outcomes.

Listing date: 03 Nov, 1994
Chairperson Name: Munir Shaikh
OrganisationAbbott India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Abbott India Ltd

What is Abbott India Ltd price today?

Abbott India Ltd share price today stands at ₹30060, Open: ₹30680, Previous Close: ₹30470, High: ₹30680, Low: ₹30010, 52 Week High: ₹31898.95, 52 Week Low: ₹25200.

How to Buy Abbott India Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Abbott India Ltd shares

What are today's traded volumes of Abbott India Ltd?

Today's traded volume of Abbott India Ltd(ABBOTINDIA) is 6,809.00.

What is today's market capitalisation of Abbott India Ltd?

Today's market capitalisation of Abbott India Ltd(ABBOTINDIA) is ₹63877.5Cr.

What is the 52 Week High and Low Range of Abbott India Ltd?

Abbott India Ltd (ABBOTINDIA)
Price
52 Week High
₹31898.95
52 Week Low
₹25200

How much percentage Abbott India Ltd is down from its 52 Week High?

Abbott India Ltd (ABBOTINDIA) share price is ₹30060. It is down -5.76% from its 52 Week High price of ₹31898.95

How much percentage Abbott India Ltd is up from its 52 Week low?

Abbott India Ltd (ABBOTINDIA) share price is ₹30060. It is up 19.29% from its 52 Week Low price of ₹25200